We also analyzed the targeting PTPN2-binding proteins and the PTPN2 expression-correlated genes and found that STAT1 and EGFR are key factors for PTPN2 to regulate the deterioration of PAAD. The gene discussed is EGFR; the disease is pancreatic adenocarcinoma.